Shares Outstanding: 72.40M
The shares outstanding is 72.40M. It is below its 12-month average by 0.44% (72.72M).
WST Shares Outstanding
Reported quarterly weighted average share count; no daily interpolation.
WST Average Shares Outstanding Chart
WST Current vs Average Shares Outstanding Chart
WST Shares Outstanding Metrics
SHARES OUTSTANDING
72.40M
SHARES OUTSTANDING AVG TTM
72.72M
SHARES OUTSTANDING AVG 3Y
73.85M
SHARES OUTSTANDING AVG 5Y
74.62M
SHARES OUTSTANDING AVG 10Y
75.36M
SHARES OUTSTANDING AVG 15Y
74.30M
SHARES OUTSTANDING AVG 20Y
73.83M
CURRENT VS TTM AVG
-0.44%
CURRENT VS 3Y AVG
-1.97%
CURRENT VS 5Y AVG
-2.98%
CURRENT VS 10Y AVG
-3.93%
CURRENT VS 15Y AVG
-2.56%
CURRENT VS 20Y AVG
-1.93%
Share Structure
Shares Outstanding
72.30M
Float Shares
N/A
Stock Price
$350.85
Market Cap
$24.8B
Quarterly Shares Outstanding History
| Period | Weighted Average Shares | QoQ Change |
|---|---|---|
| Q1 2026 | 72.40M | -0.41% |
| Q4 2025 | 72.70M | +0.00% |
| Q3 2025 | 72.70M | -0.14% |
| Q2 2025 | 72.80M | -0.27% |
| Q1 2025 | 73.00M | -0.95% |
| Q4 2024 | 73.70M | +0.41% |
| Q3 2024 | 73.40M | -0.41% |
| Q2 2024 | 73.70M | -0.81% |
| Q1 2024 | 74.30M | -0.93% |
| Q4 2023 | 75.00M | -0.40% |
| Q3 2023 | 75.30M | -0.13% |
| Q2 2023 | 75.40M | -0.40% |
| Q1 2023 | 75.70M | +0.13% |
| Q4 2022 | 75.60M | -0.13% |
| Q3 2022 | 75.70M | -0.13% |
| Q2 2022 | 75.80M | -0.26% |
| Q1 2022 | 76.00M | -0.52% |
| Q4 2021 | 76.40M | +0.53% |
| Q3 2021 | 76.00M | +0.40% |
| Q2 2021 | 75.70M | -0.13% |
| Q1 2021 | 75.80M | -0.39% |
| Q4 2020 | 76.10M | +0.40% |
| Q3 2020 | 75.80M | +0.40% |
| Q2 2020 | 75.50M | +0.00% |
| Q1 2020 | 75.50M | -0.26% |
| Q4 2019 | 75.70M | +0.26% |
| Q3 2019 | 75.50M | +0.53% |
| Q2 2019 | 75.10M | -0.27% |
| Q1 2019 | 75.30M | -0.26% |
| Q4 2018 | 75.50M | -0.26% |
| Q3 2018 | 75.70M | +0.93% |
| Q2 2018 | 75.00M | -0.66% |
| Q1 2018 | 75.50M | -0.53% |
| Q4 2017 | 75.90M | +0.00% |
| Q3 2017 | 75.90M | +0.13% |
| Q2 2017 | 75.80M | +1.20% |
| Q1 2017 | 74.90M | +0.00% |
| Q4 2016 | 74.90M | -0.13% |
| Q3 2016 | 75.00M | +0.27% |
| Q2 2016 | 74.80M | +0.94% |
| Q1 2016 | 74.10M | +0.00% |
| Q4 2015 | 74.10M | +0.27% |
| Q3 2015 | 73.90M | +0.27% |
| Q2 2015 | 73.70M | +0.55% |
| Q1 2015 | 73.30M | +0.14% |
| Q4 2014 | 73.20M | +0.83% |
| Q3 2014 | 72.60M | +0.28% |
| Q2 2014 | 72.40M | +0.14% |
| Q1 2014 | 72.30M | +0.14% |
| Q4 2013 | 72.20M | +1.12% |
| Q3 2013 | 71.40M | +0.85% |
| Q2 2013 | 70.80M | +0.85% |
| Q1 2013 | 70.20M | +0.29% |
| Q4 2012 | 70.00M | +0.86% |
| Q3 2012 | 69.40M | -5.19% |
| Q2 2012 | 73.20M | -1.35% |
| Q1 2012 | 74.20M | +0.00% |
| Q4 2011 | 74.20M | +0.27% |
| Q3 2011 | 74.00M | +0.00% |
| Q2 2011 | 74.00M | +0.54% |
| Q1 2011 | 73.60M | +0.00% |
| Q4 2010 | 73.60M | +0.27% |
| Q3 2010 | 73.40M | +0.00% |
| Q2 2010 | 73.40M | +0.55% |
| Q1 2010 | 73.00M | +0.00% |
| Q4 2009 | 73.00M | +0.27% |
| Q3 2009 | 72.80M | +0.55% |
| Q2 2009 | 72.40M | +0.28% |
| Q1 2009 | 72.20M | +0.00% |
| Q4 2008 | 72.20M | -0.28% |
| Q3 2008 | 72.40M | -0.28% |
| Q2 2008 | 72.60M | +0.55% |
| Q1 2008 | 72.20M | +0.00% |
| Q4 2007 | 72.20M | -1.90% |
| Q3 2007 | 73.60M | -0.81% |
| Q2 2007 | 74.20M | +7.54% |
| Q1 2007 | 69.00M | +0.00% |
| Q4 2006 | 69.00M | +2.07% |
| Q3 2006 | 67.60M | +0.72% |
| Q2 2006 | 67.12M | +1.38% |
| Q1 2006 | 66.20M | -0.08% |
| Q4 2005 | 66.25M | +1.06% |
| Q3 2005 | 65.55M | +1.93% |
| Q2 2005 | 64.31M | +1.20% |
| Q1 2005 | 63.55M | +0.00% |
| Q4 2004 | 63.55M | +1.61% |
| Q3 2004 | 62.54M | +1.85% |
| Q2 2004 | 61.41M | +1.89% |
| Q1 2004 | 60.27M | +0.00% |
| Q4 2003 | 60.27M | +3.21% |
| Q3 2003 | 58.40M | +0.80% |
| Q2 2003 | 57.93M | +0.02% |
| Q1 2003 | 57.92M | +0.00% |
| Q4 2002 | 57.92M | +0.12% |
| Q3 2002 | 57.85M | -0.30% |
| Q2 2002 | 58.03M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Shares Outstanding Formula & Definition
Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shares Outstanding FAQ
- What is the shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The shares outstanding for WST stock is 72.40M.
- What is the TTM average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The TTM average shares outstanding for WST stock is 72.72M.
- What is the 3Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The 3Y average shares outstanding for WST stock is 73.85M.
- What is the 5Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The 5Y average shares outstanding for WST stock is 74.62M.
- What is the 10Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The 10Y average shares outstanding for WST stock is 75.36M.
- What is the 15Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The 15Y average shares outstanding for WST stock is 74.30M.
- What is the 20Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
- The 20Y average shares outstanding for WST stock is 73.83M.
WST Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2026-03-31 | 72.40M |
| 2025-12-31 | 72.70M |
| 2025-09-30 | 72.70M |
| 2025-06-30 | 72.80M |
| 2025-03-31 | 73.00M |
| 2024-12-31 | 73.70M |
| 2024-09-30 | 73.40M |
| 2024-06-30 | 73.70M |
| 2024-03-31 | 74.30M |
| 2023-12-31 | 75.00M |
| 2023-09-30 | 75.30M |
| 2023-06-30 | 75.40M |
| 2023-03-31 | 75.70M |
| 2022-12-31 | 75.60M |
| 2022-09-30 | 75.70M |
| 2022-06-30 | 75.80M |
| 2022-03-31 | 76.00M |
| 2021-12-31 | 76.40M |
| 2021-09-30 | 76.00M |
| 2021-06-30 | 75.70M |
| 2021-03-31 | 75.80M |
| 2020-12-31 | 76.10M |
| 2020-09-30 | 75.80M |
| 2020-06-30 | 75.50M |
| 2020-03-31 | 75.50M |
| 2019-12-31 | 75.70M |
| 2019-09-30 | 75.50M |
| 2019-06-30 | 75.10M |
| 2019-03-31 | 75.30M |
| 2018-12-31 | 75.50M |
| 2018-09-30 | 75.70M |
| 2018-06-30 | 75.00M |
| 2018-03-31 | 75.50M |
| 2017-12-31 | 75.90M |
| 2017-09-30 | 75.90M |
| 2017-06-30 | 75.80M |
| 2017-03-31 | 74.90M |
| 2016-12-31 | 74.90M |
| 2016-09-30 | 75.00M |
| 2016-06-30 | 74.80M |
| 2016-03-31 | 74.10M |
| 2015-12-31 | 74.10M |
| 2015-09-30 | 73.90M |
| 2015-06-30 | 73.70M |
| 2015-03-31 | 73.30M |
| 2014-12-31 | 73.20M |
| 2014-09-30 | 72.60M |
| 2014-06-30 | 72.40M |
| 2014-03-31 | 72.30M |
| 2013-12-31 | 72.20M |
| 2013-09-30 | 71.40M |
| 2013-06-30 | 70.80M |
| 2013-03-31 | 70.20M |
| 2012-12-31 | 70.00M |
| 2012-09-30 | 69.40M |
| 2012-06-30 | 73.20M |
| 2012-03-31 | 74.20M |
| 2011-12-31 | 74.20M |
| 2011-09-30 | 74.00M |
| 2011-06-30 | 74.00M |
| 2011-03-31 | 73.60M |
| 2010-12-31 | 73.60M |
| 2010-09-30 | 73.40M |
| 2010-06-30 | 73.40M |
| 2010-03-31 | 73.00M |
| 2009-12-31 | 73.00M |
| 2009-09-30 | 72.80M |
| 2009-06-30 | 72.40M |
| 2009-03-31 | 72.20M |
| 2008-12-31 | 72.20M |
| 2008-09-30 | 72.40M |
| 2008-08-05 | 72.60M |
| 2008-03-31 | 72.20M |
| 2007-12-31 | 72.20M |
| 2007-09-30 | 73.60M |
| 2007-06-30 | 74.20M |
| 2007-03-31 | 69.00M |
| 2006-12-31 | 69.00M |
| 2006-09-30 | 67.60M |
| 2006-06-30 | 67.12M |
| 2006-03-31 | 66.20M |
| 2005-12-31 | 66.25M |
| 2005-09-30 | 65.55M |
| 2005-06-30 | 64.31M |
| 2005-03-31 | 63.55M |
| 2004-12-31 | 63.55M |
| 2004-09-30 | 62.54M |
| 2004-06-30 | 61.41M |
| 2004-03-31 | 60.27M |
| 2003-12-31 | 60.27M |
| 2003-09-30 | 58.40M |
| 2003-06-30 | 57.93M |
| 2003-03-31 | 57.92M |
| 2002-12-31 | 57.92M |
| 2002-09-30 | 57.85M |
| 2002-06-30 | 58.03M |
Related Metrics
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green